535 Phase I study of a new Halichondrin B analog, E7389, administered by 1-hour IV infusion every 21 days

2004 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    1
    Citations
    NaN
    KQI
    []